Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Danziger & De Llano, LLP Launches New Campaign to Help Victims of Victoza Treatments

 



(Medical-NewsWire.com, September 20, 2013 )

Los Angeles, CA -- Danziger & De Llano, LLP, a law firm that fights for justice on behalf of individuals, families, and businesses, recently announced their decision to start a new campaign that helps victims interested in filing Victoza lawsuits. According to the campaign information page, located at http://www.after-cancer.com/victoza-lawsuit, Danziger & De Llano, LLP can help victims file lawsuits against Novo Nordisk, the manufacturer of Victoza.



Victoza, also known as Liraglutide, was first introduced into the American market in early 2010 as a treatment for type II diabetes. Due to the severity of type II diabetes, which can cause obesity, heart problems, and circulatory problems credited to a lack of insulin, new medication is always a cause for hope.



However, Victoza caused serious health concerns. Before Victoza was introduced to the public, thyroid cancer showed up in the laboratory rats that were used during the medical’s pre-release clinical lab studies. Additionally, in 2013, the FDA revealed its determination to review the findings of a new study that linked Victoza to pancreatic cancer and pancreatitis. Both of these diseases have caused deaths in Victoza patients.



“Though the company attempted to diffuse these concerns by indicating that the results were specific to rats and would not be applicable for human patients, questions remain,” stated an article on after-cancer.com/victoza-lawsuit. “Since that time the drug’s manufacturer, Novo Nordisk, has also been criticized for marketing the medication before it was approved.”



Danziger & De Llano, LLP encourages all victims and their families to come forward for help. The law firm recommends consulting a physician immediately to discuss the risks involved with taking Victoza. If any Victoza patient has been diagnosed with pancreatitis, pancreatic cancer, or thyroid cancer since starting the treatment, then they may be eligible to file a lawsuit against Novo Nordisk.



Individuals interested in learning more about Danziger & De Llano, LLP and its work with Victoza patients can visit http://after-cancer.com/victoza-lawsuit for more information.



About Danziger & De Llano, LLP:



Danziger & De Llano, LLP is a law firm dedicated to helping businesses, individuals, and their families. The firm is committed to providing its clients with superior client service and personal attention. When Danziger & De Llano, LLP accepts a case, it assigns a team of professionals including attorneys, legal assistants and support staff to guide the client through the legal process. Danziger & De Llano, LLP is devoted to ensuring that each client obtains full and just compensation for all of their injuries. For more information, please visit http://www.after-cancer.com/victoza-lawsuit



###

Danziger & De Llano

Lionel Ortega

(949) 555-2861

admin@rocketfactor.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC